Chronic non-ischaemic congestive heart disease and endomyocardial biopsies. Worth the extra?

A E Becker1, C D Heijmans, C E Essed

  • 1Department of Pathology, University of Amsterdam, The Netherlands.

European Heart Journal
|February 1, 1991
PubMed

Insights

Endomyocardial biopsies have limited diagnostic value for non-ischaemic heart failure, often showing non-specific findings or missing myocarditis due to sampling errors. These biopsies still aid in patient categorization and management.

Area of Science:

  • Cardiology
  • Pathology
  • Transplantation Medicine

Background:

  • The diagnostic utility of endomyocardial biopsies (EMBs) in chronic congestive heart failure (CHF) of non-ischaemic origin is debated.
  • Accurate diagnosis is crucial for effective management and treatment strategies in non-ischaemic CHF.

Purpose of the Study:

  • To evaluate the correlation between histologic findings from EMBs and cardiac explants in patients with non-ischaemic CHF.
  • To assess the diagnostic yield of EMBs in this specific patient population.

Main Methods:

  • Retrospective analysis of 13 patients undergoing cardiac transplantation.
  • Comparison of histological interpretations of pre-transplant EMBs with corresponding cardiac explant diagnoses.

Main Results:

  • Biopsy diagnoses included 'compatible with dilated cardiomyopathy' (6), 'non-conclusive' (4), 'ischaemia' (2), and 'borderline myocarditis' (1).
  • Explant analysis revealed myocyte hypertrophy as a common finding; myocarditis was missed in 4 biopsies, potentially due to sampling error or timing.
  • Discrepancies highlight limitations in diagnosing specific conditions like myocarditis via EMBs in non-ischaemic CHF.

Conclusions:

  • EMBs offer minimal immediate diagnostic yield for non-ischaemic CHF, especially for myocarditis.
  • Despite limitations, EMBs contribute to the overall categorization and management decisions for these patients.
  • Sampling error and time intervals significantly impact diagnostic accuracy.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...